• Investing
  • Trading
  • Options
  • Technology
  • Energy
LoginMy Member Benefitsarchivesresearchyour teamabout usFAQLog out

Share This Article

Facebook LinkedIn
Twitter Google+
Reddit Print
Email Pinterest
Delicious StumbleUpon
Gmail Yahoo
Tumblr Digg
  • Our FlagshipMoney Morning
  • Michael A. Robinson'sStrategic Tech Investor
  • Shah Gilani'sWall Street Insights & Indictments
  • YourProfit Alerts
  • Keith Fitz-Gerald'sTotal Wealth
  • Dr. Kent Moors'Oil & Energy Investor
  • Tom Gentile'sPower Profit Trades
  • Lee Adler'sSure Money Investor
  • D.R. Barton's10-Minute Millionaire
  • Tim Melvin'sMax Wealth
  • Research ServicesMoney Map Press
Money Morning
Archives Research Your Team About Us FAQ Videos
  • Investing
  • Trading
  • Options
  • Technology
  • Energy
Money Morning tablet view
HOME

Email this Article

Send with mail | ahoo instead.
Required Needs to be a valid email
Required Needs to be a valid email
Stock Market Overview
https://mney.co/2vnfXpo
Required Please enter the correct value.
Share
Twitter
Why this score matters The Money Morning Stock VQScore™
×

Get free access to all the Money Morning stock ratings right now to find out which stocks scored at the top of our list. Just enter your email address:

By submitting your email address you will receive a free subscription to Money Morning and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.​​

Latest Updates on GSK
  • dow jones
    Dow Jones

    Dow Jones Industrial Average Rallies Today Ahead of FOMC Decision

    By Garrett Baldwin, Economist, Money Morning • December 19, 2018

    The Dow Jones Industrial Average is rallying early Wednesday ahead of today's critical announcement by the Federal Reserve on interest rates. Despite outrage from President Donald Trump, the U.S. central bank is expected to hike interest … Read more »
  • Biotech
    Technology

    This Is Your Next Step to a Biotech Windfall in 2018

    By Cooper Creagan, Associate Editor, Money Morning • October 18, 2017

    The biotech landscape is about to change. Yes, you could invest in a company that might produce a great new treatment. Read more »
  • stocks to watch
    Stocks

    Why Activision Blizzard, Alphabet, and GlaxoSmithKline Are Stocks to Watch Now

    By Stephen Mack, Associate Editor, Money Morning • September 22, 2017

    Our latest list of stocks to watch now includes a gaming company with a new e-sports league, an Internet giant solidifying its move into the mobile phone market, and an FDA win for a newly streamlined pharma company. Read more »
  • stock
    Biotechnology

    Artificial Intelligence and Biotech Are Merging to Bring You Monster Profits

    This expert insight from Michael A. Robinson originally ran in Strategic Tech Investor on July 19, 2017

    In biotech, one thing isn't going to change. The "bread and butter" technology that makes up 90% of the pharmaceutical market - good, old-fashioned small molecules, created in the laboratory - isn't going anywhere. Yes, incredibly … Read more »
  • best stocks to buy now
    Stocks

    The Best Stocks to Buy Now (and One Stinker to Short)

    By Stephen Mack, Associate Editor, Money Morning • June 2, 2017

    Our newest list of best stocks to buy now has four picks from tech - from pharmaceuticals and consumer healthcare, to dental technology and the Internet of Everything. Read more »
  • stocks to watch
    Stocks

    Top Stocks to Watch Today (March 8, 2017): DIS, GSK, EXPR

    By Ashley Moore, Associate Editor, Money Morning • March 8, 2017

    The top three stocks to watch for today are DIS, GSK, and EXPR. For the first time in six years, the barometer for global economic health has increased by over 9%. Read more »
  • drug price increases
    Biotechnology

    5 Drug Price Increases That Will Have You Seeing Red

    By David Zeiler, Associate Editor, Money Morning • @DavidGZeiler • October 28, 2016

    Americans need to brace themselves for more drug price increases, as they're not as unusual as you might think. Although the most outrageous drug price hikes, like Turing Pharmaceutical's 5,455% increase in the price of Daraprim, get a lot … Read more »

© 2019 All market data provided and hosted by Barchart Solutions.

Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.​

ABOUT MONEY MORNING

Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Login to Private Briefing
FREE NEWSLETTERS
Strategic Tech Investor Oil & Energy Investor Total Wealth Research Wall Street Insights & Indictments Power Profit Trades Sure Money Investor 10 Minute Millionaire Max Wealth
PREMIUM SERVICES
Money Map Press Home Money Map Report Energy Advantage Nova-X Report Private Briefing Fast Fortune Club Energy Inner Circle High Velocity Profits Biotech Insider Alert Radical Technology Profits Stealth Profits Trader Money Calendar Pro Weekly Money Call Zenith Trading Circle Seismic Profits Alert The 10-Minute Millionaire Insider Night Trader Cryptocurrency Windfalls The Money Zone Heatseekers Alpha-9 Trader Straight Line Profits
Get In Touch
Like Our Page
Follow Us
Watch Us on YouTube
Connect with Us

© 2019 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles Street | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us

You may choose from these hot topics to start receiving our money-making recommendations in real time.

Don't forget choose a topic.
View all topics

Interested in other topics? You can add more alerts below.

Plan & Protect:Select All
Make Fast Money:Select All
Get in on the Ground Floor:Select All
Track the Markets:Select All
Follow the Experts:Select All
We respect your privacy. Learn more.
By submitting your email address you will receive a free subscription to Money Morning and receive Money Morning Profit Alerts. You will also receive occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.